Cargando…

Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the critically ill and is associated with adverse outcomes. Although there are plausible benefits from conversion and maintenance of sinus rhythm (the so-called 'rhythm-control' strategy), recent randomized trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hoong Sern, Hamaad, Ali, Lip, Gregory YH
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522829/
https://www.ncbi.nlm.nih.gov/pubmed/15312210
http://dx.doi.org/10.1186/cc2827
_version_ 1782121856547946496
author Lim, Hoong Sern
Hamaad, Ali
Lip, Gregory YH
author_facet Lim, Hoong Sern
Hamaad, Ali
Lip, Gregory YH
author_sort Lim, Hoong Sern
collection PubMed
description Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the critically ill and is associated with adverse outcomes. Although there are plausible benefits from conversion and maintenance of sinus rhythm (the so-called 'rhythm-control' strategy), recent randomized trials have failed to demonstrate the superiority of this approach over the rate-control strategy. Regardless of approach, continuous therapeutic anticoagulation is crucial for stroke prevention. This review addresses the findings of these studies and their implications for clinical management of patients with atrial fibrillation.
format Text
id pubmed-522829
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5228292004-10-17 Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control Lim, Hoong Sern Hamaad, Ali Lip, Gregory YH Crit Care Review Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the critically ill and is associated with adverse outcomes. Although there are plausible benefits from conversion and maintenance of sinus rhythm (the so-called 'rhythm-control' strategy), recent randomized trials have failed to demonstrate the superiority of this approach over the rate-control strategy. Regardless of approach, continuous therapeutic anticoagulation is crucial for stroke prevention. This review addresses the findings of these studies and their implications for clinical management of patients with atrial fibrillation. BioMed Central 2004 2004-02-19 /pmc/articles/PMC522829/ /pubmed/15312210 http://dx.doi.org/10.1186/cc2827 Text en Copyright © 2004 BioMed Central Ltd
spellingShingle Review
Lim, Hoong Sern
Hamaad, Ali
Lip, Gregory YH
Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
title Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
title_full Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
title_fullStr Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
title_full_unstemmed Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
title_short Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
title_sort clinical review: clinical management of atrial fibrillation – rate control versus rhythm control
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522829/
https://www.ncbi.nlm.nih.gov/pubmed/15312210
http://dx.doi.org/10.1186/cc2827
work_keys_str_mv AT limhoongsern clinicalreviewclinicalmanagementofatrialfibrillationratecontrolversusrhythmcontrol
AT hamaadali clinicalreviewclinicalmanagementofatrialfibrillationratecontrolversusrhythmcontrol
AT lipgregoryyh clinicalreviewclinicalmanagementofatrialfibrillationratecontrolversusrhythmcontrol